Abbott Laboratories (ETR:ABL)
113.98
+0.22 (0.19%)
Apr 24, 2025, 5:35 PM CET
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $10.36B USD in the quarter ending March 31, 2025, with 3.95% growth. This brings the company's revenue in the last twelve months to $42.34B, up 5.00% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$42.34B
Revenue Growth
+5.00%
P/S Ratio
5.06
Revenue / Employee
$371.44K
Employees
114,000
Market Cap
198.09B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Abbott Laboratories News
- 1 day ago - 2025 Dividend Kings: Weathering Tariff Volatility Better Than The Market - Seeking Alpha
- 5 days ago - Abbott Labs' Rally Is Well Deserved - Fade The Rally For Now - Seeking Alpha
- 6 days ago - Abbott Labs is a textbook recession play, says Jim Cramer - CNBC
- 7 days ago - These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings - Benzinga
- 7 days ago - These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings - Benzinga
- 7 days ago - US Stocks Likely To Open Higher Ahead Of Festive Weekend: 'Current Equity Levels Offer An Attractive Entry Opportunity' - Benzinga
- 7 days ago - Abbott Q1: Flexible Supply Chain And Strong Growth In Medical Devices - Seeking Alpha
- 8 days ago - Abbott Labs Stock Jumps on Strong Earnings, With $500M Investment in US Facilities - Investopedia